Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE2268 dose-response add-on study in type 2 diabetes inadequately controlled on metformin
2006-001843-74Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Atigliflozin in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Sanofi. Started Jun 2006; status: completed.
02
Drugs
Atigliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-001843-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001843-74.